RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to stop aggressive breast Cancer's return
Disease control OngoingThis study is testing the safety of a drug called niraparib when given alongside standard radiation therapy after surgery. It involves 21 adults with triple-negative breast cancer who still have some cancer cells left after initial treatment. The goal is to see if this combinatio…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Vaccine trial aims to stop aggressive breast Cancer's return
Prevention OngoingThis study is testing two different vaccines designed to prevent breast cancer from returning in patients with HER2-positive disease. It focuses on people who still had cancer cells remaining after completing their initial chemotherapy and targeted therapy. Researchers will monit…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC